BISMUSAL: Product Information

BISMUSAL — bismuth subsalicylate suspension
Sparhawk Laboratories, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

FOR ORAL USE ONLY

SHAKE WELL BEFORE USING

INDICATIONS

A palatable oral suspension for use as an aid in the control of simple diarrhea in cattle, horses and dogs.

CONTRAINDICATION

Not recommended for use in cats.

CAUTION

This product contains salicylate; do not administer with other salicylate-containing products, such as aspirin.

DOSAGE AND ADMINISTRATION

Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.

Dogs- 1 to 3 tablespoons

Calves- 3 to 4 ounces

Foals- 3 to 4 ounces

Cattle and Horses- 6-10 fl. ozs.

This product may cause stools to darken. If diarrhea persists after using this product for 2 days, contact veterinarian.

COMPOSITION

Bismuth Subsalicylate ……….. 1.75%

in a palatable aqueous suspension. Flavoring and coloring added.

Store at room temperature not above 37°C (98.6°F)

Protect from freezing.

TAKE TIME OBSERVE LABEL DIRECTIONS

BISMUSAL bismuth subsalicylate suspension

Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:58005-700 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BISMUTH SUBSALICYLATE (BISMUTH CATION) BISMUTH SUBSALICYLATE 66.2 g in 3.785 L

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:58005-700-07 3.785 L in 1 JUG None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/18/2009

Labeler — Sparhawk Laboratories, Inc. (147979082)

Revised: 10/2017 Sparhawk Laboratories, Inc.